Trial Profile
A retrospective trial to evaluate the efficacy of bevacizumab- or cetuximab-based chemotherapy in patients with resected colorectal cancer liver metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cetuximab (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 29 Mar 2016 New trial record